ARCHIVES

VEGF Levels Can Predict Tumor’s Resistance to Avastin

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Develops Cancer Genetics Curriculum

December 18, 1998

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

The March: Cancer Centers To Plan Events In Conjunction With Sept. 26 March

April 10, 1998

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991